Popular stocks:

AMC Entertainment

GameStop

Zomedica

Churchill Capital Corp IV

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

AbbVie (ABBV) stock forecast for 2022

The forecast has been updated: November 23, 2022 7:24

AbbVie stock price online today

Analyst Target Price

159.44

Dividend Date

15.02.2023

Ex Dividend Date

12.01.2023

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell AbbVie stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? AbbVie stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $159.44 target price for AbbVie stock stock.

Today 200 Day Moving Average is the resistance level (148.4 $).

50 Day Moving Average is the support level (145.15 $).

ABBV Forecast for 2022

Month	Rate Forecast	MIN Rate	MAX Rate	Volati- lity, %
Dec	144.82	141.34	148.06	4.54 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of AbbVie stock.

AbbVie overview

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization

281 959 399 000 $

EBITDA

29 401 000 000

PE Ratio

21.26

PEG Ratio

1.279

Dividend Per Share

5.64

Dividend Yield

0.0377

EPS

7.5

Quarterly Earnings Growth YOY

0.242

Quarterly Revenue Growth YOY

0.033

Trailing PE

21.26

Forward PE

13.66

EV To Revenue

5.74

EV To EBITDA

19.6

52 Week High

171.07

52 Week Low

110.78

50 Day Moving Average

145.15

200 Day Moving Average

148.4

Shares Outstanding

1768480000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

AbbVie stock forecast for this year

AbbVie stock forecast for Dec 2022.
Estimated Average Forecasted AbbVie Price: 144.82. Positive monthly dynamics of the instrument is expected with 4.538% volatility is expected.

Pessimistic forecast: 141.34

Optimistic: 148.06

All currency forecasts

All stock predictions

All cryptocurrency predictions

All stock index forecasts

Other Healthcare sector assets

Name	Symbol	Last Close Price	Change
Abbott Laboratories	ABT	98.07 (04.11.2022)	1.68 %
AbbVie Inc.	ABBV	145.28 (04.11.2022)	0.60 %
Aeterna Zentaris Inc.	AEZS	4.01 (04.11.2022)	2.82 %
Allakos Inc.	ALLK	5.99 (04.11.2022)	5.83 %
Allogene Therapeutics, Inc.	ALLO	9.34 (04.11.2022)	-1.89 %
Amgen Inc.	AMGN	269.04 (04.11.2022)	1.19 %
Aphria Inc.	APHA	15.38 (07.05.2021)	0.00 %
Atara Biotherapeutics, Inc.	ATRA	4.75 (04.11.2022)	2.15 %
Aurora Cannabis Inc.	ACB	1.31 (04.11.2022)	-5.07 %
Becton Dickinson and Company	BDX	220.84 (04.11.2022)	-0.07 %
Biogen Inc.	BIIB	281.82 (04.11.2022)	0.56 %
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	15.47 (04.11.2022)	4.60 %
BioNTech SE	BNTX	154.31 (04.11.2022)	6.24 %
bluebird bio, Inc.	BLUE	6.13 (04.11.2022)	-2.23 %
Boston Scientific Corp.	BSX	41.59 (04.11.2022)	0.14 %
Bristol-Myers Squibb Company	BMY	78.78 (04.11.2022)	0.38 %
Canopy Growth Corp.	CGC	3.29 (04.11.2022)	-4.64 %
Castle Biosciences, Inc.	CSTL	21.94 (04.11.2022)	-9.60 %
CLOVER HEALTH INVESTMENTS, CORP	CLOV	3.16 (07.01.2022)	-5.67 %
Eli Lilly and Company	LLY	242.27 (04.02.2022)	0.00 %
Emergent BioSolutions Inc.	EBS	19.96 (04.11.2022)	2.20 %
Exelixis, Inc.	EXEL	18.56 (17.06.2022)	5.63 %
G1 Therapeutics, Inc.	GTHX	8.32 (04.11.2022)	4.92 %
Gilead Sciences, Inc.	GILD	80.34 (04.11.2022)	1.11 %
GlaxoSmithKline plc	GSK	32.99 (04.11.2022)	0.46 %
GoodRx Holdings, Inc.	GDRX	5.06 (04.11.2022)	3.27 %
GW Pharmaceuticals plc.	GWPH	218.96 (05.05.2021)	0.00 %
Incyte Corp.	INCY	77.3 (04.11.2022)	0.52 %
Inovio Pharmaceuticals, Inc.	INO	2.11 (04.11.2022)	-1.40 %
Johnson & Johnson	JNJ	171.48 (04.11.2022)	0.45 %
Medtronic plc.	MDT	84.65 (04.11.2022)	0.75 %
Merck & Co., Inc.	MRK	99.2 (04.11.2022)	0.46 %
Moderna, Inc.	MRNA	158.41 (04.11.2022)	7.40 %
Novartis AG	NVS	81.72 (04.11.2022)	1.67 %
Novavax, Inc.	NVAX	19.4 (04.11.2022)	-3.82 %
ObsEva SA	OBSV	0.1688 (04.11.2022)	0.60 %
OrganiGram Holdings Inc.	OGI	0.9738 (04.11.2022)	0.11 %
Pfizer Inc.	PFE	47.22 (04.11.2022)	1.40 %
Regeneron Pharmaceuticals, Inc.	REGN	740.21 (04.11.2022)	0.21 %
Sanofi	SNY	43.62 (04.11.2022)	1.82 %
Schrodinger, Inc.	SDGR	20.92 (04.11.2022)	-15.17 %
Senseonics Holdings, Inc.	SENS	1.18 (04.11.2022)	-0.84 %
Sorrento Therapeutics, Inc.	SRNE	1.46 (04.11.2022)	-1.35 %
Stryker Corp.	SYK	210.98 (04.11.2022)	2.66 %
Sundial Growers Inc.	SNDL	2.32 (04.11.2022)	-2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)	TEVA	8.47 (04.11.2022)	-1.63 %
Thermo Fisher Scientific Inc.	TMO	495.55 (04.11.2022)	1.77 %
Tilray, Inc.	TLRY	3.81 (04.11.2022)	-0.26 %
UnitedHealth Group, Inc.	UNH	538.17 (04.11.2022)	-1.00 %
Veeva Systems Inc.	VEEV	166.81 (04.11.2022)	-0.20 %
Zomedica Corp.	ZOM	0.2245 (04.11.2022)	-2.01 %
Zynerba Pharmaceuticals, Inc.	ZYNE	0.7051 (04.11.2022)	-2.07 %

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.